help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 23, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1550
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/1/260    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, Y.
Right arrow Articles by Wang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, Y.
Right arrow Articles by Wang, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
*Genetics Home Reference
Medline Plus Health Information
*High Risk Pregnancy
Related Collections
Right arrow Female Endocrinology

Submitted on July 12, 2007
Accepted on October 12, 2007

Placental Productions and Expressions of sEndoglin, sFlt-1, and PlGF in Normal and Preeclamptic Pregnancies

Yang Gu, David F. Lewis, and Yuping Wang*

Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, LA 71130

* To whom correspondence should be addressed. E-mail: ywang1{at}lsuhsc.edu.

Context: Increased productions of anti-angiogenic factors sEng and sFlt-1 by the placenta contribute to the pathophysiology in preeclampsia (PE).

Objective: To determine the differences in Eng, Flt-1 and PlGF expressions between normal and PE placentas and sEng, sFlt-1 and PlGF production by trophoblasts (TC) cultured under lowered oxygen conditions.

Methods: TCs isolated from normal and PE placentas were cultured under regular (5%CO2/air) and lowered (2%O2/5%CO2/93%N2) oxygen conditions. sEng, sFlt-1, and PlGF productions were determined by ELISA. Protein expressions for endoglin, Flt-1, and PlGF in the placental tissues were accessed by immunohistochemical staining and Western blot analysis. Deglycosylated endoglin, Flt-1 and PlGF protein expressions in placental tissues were also examined.

Results: 1) PE-TCs produced significantly more sEng, sFlt-1 and PlGF compared to those from normal-TCs, P< 0.05; 2) Under lowered oxygen conditions, PE-TCs, but not normal-TCs, released more sEng and sFlt-1. In contrast, both normal- and PE-TCs released less PlGF, P< 0.05; 3) Enhanced expressions of endoglin and Flt-1, as well as glycosylated endoglin and Flt-1, were observed in PE placentas; and 4) Immunoblot also revealed that TCs released glycosylated sFlt-1, but not sEng, in culture.

Conclusions: PE-TCs produce more sEng, sFlt-1 and PlGF than normal-TCs. Lowered oxygen conditions promote sEng and sFlt-1, but reduce PlGF, productions by PE-TCs. More glycosylated sEng and sFlt-1 are present in PE placentas. Trophoblasts release glycosylated sFlt-1, but unglycosylated sEng, in culture.


Key words: placenta • sEng • sFlt-1 • PlGF • preeclampsia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society